Faster, But…

While patients and their advocates hope that the new 21st Century Cures Act, which was passed by Congress last month, will get treatments approved faster, others worry that changes to how the US Food and Drug Administration regulates drugs and medical devices could make patients vulnerable, NPR reports.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.